The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human Keratinocytes
Open accessAbstract
The L1 major capsid protein of human papillomavirus (HPV) type 11, a 55-kDa polypeptide, forms particulate structures resembling native virus with an average particle diameter of 50-60 nm when expressed in the yeast Saccharomyces cerevisiae. We show in this report that these virus-like particles (VLPs) interact with heparin and with cell-surface glycosaminoglycans (GAGs) resembling heparin on keratinocytes and Chinese hamster ovary cells. The binding of VLPs to heparin is shown to exhibit an affinity comparable to that of other identified heparin-binding proteins. Immobilized heparin chromatography and surface plasmon resonance were used to show that this interaction can be specifically inhibited by free heparin and dextran sulfate and that the effectiveness of the inhibitor is related to its molecular weight and charge density. Sequence comparison of nine human L1 types revealed a conserved region of the carboxyl terminus containing clustered basic amino acids that bear resemblance to proposed heparin-binding motifs in unrelated proteins. Specific enzymatic cleavage of this region eliminated binding to both immobilized heparin and human keratinocyte (HaCaT) cells. Removal of heparan sulfate GAGs on keratinocytes by treatment with heparinase or heparitinase resulted in an 80-90% reduction of VLP binding, whereas treatment of cells with laminin, a substrate for alpha6 integrin receptors, provided minimal inhibition. Cells treated with chlorate or substituted beta-D-xylosides, resulting in undersulfation or secretion of GAG chains, also showed a reduced affinity for VLPs. Similarly, binding of VLPs to a Chinese hamster ovary cell mutant deficient in GAG synthesis was shown to be only 10% that observed for wild type cells. This report establishes for the first time that the carboxyl-terminal portion of HPV L1 interacts with heparin, and that this region appears to be crucial for interaction with the cell surface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.21 · Cited by 1,301
Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,210
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes
Jackson, R. L., Busch, S. J., & Cardin, A. D. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.2.481 · Cited by 1,094
Stenberg, E., Persson, B., Roos, H., & Urbaniczky, C. (1991) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(91)90284-f · Cited by 1,059
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Gissmann, L., Wolnik, L., Ikenberg, H., Koldovsky, U., Schnürch, H. G., & zur Hausen, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.560 · Cited by 880
zur Hausen, H. (1991) · Science · doi:10.1126/science.1659743 · Cited by 784
Animal cell mutants defective in glycosaminoglycan biosynthesis.
Esko, J. D., Stewart, T. E., & Taylor, W. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3197 · Cited by 513
Biosynthesis of Human Papillomavirus from a Continuous Cell Line Upon Epithelial Differentiation
Meyers, C., Frattini, M. G., Hudson, J. B., & Laimins, L. A. (1992) · Science · doi:10.1126/science.1323879 · Cited by 455
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
Evander, M., Frazer, I. H., Payne, E., Qi, Y. M., Hengst, K., & McMillan, N. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2449-2456.1997 · Cited by 390
Baker, T. S., Newcomb, W. W., Olson, N. H., Cowsert, L. M., Olson, C., & Brown, J. C. (1991) · Biophysical Journal · doi:10.1016/s0006-3495(91)82181-6 · Cited by 385
Rose, R. C., Bonnez, W., Reichman, R. C., & Garcea, R. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1936-1944.1993 · Cited by 381
STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
Choay, J., Lormeau, J., Petitou, M., Sinay, P., & Fareed, J. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb29770.x · Cited by 224
Structure of viruses of the papilloma-polyoma type
Klug, A., & Finch, J. T. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80066-3 · Cited by 202
Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules
Tal-Singer, R., Peng, C., Ponce De Leon, M., Abrams, W. R., Banfield, B. W., Tufaro, F., Cohen, G. H., & Eisenberg, R. J. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4471-4483.1995 · Cited by 193
Nature of the interaction of heparin with acidic fibroblast growth factor
Mach, H., Volkin, D. B., Burke, C. J., Middaugh, C. R., Linhardt, R. J., Fromm, J. R., Loganathan, D., & Mattsson, L. (1993) · Biochemistry · doi:10.1021/bi00071a026 · Cited by 189
Pattern and Spacing of Basic Amino Acids in Heparin Binding Sites
Fromm, J. R., Hileman, R. E., Caldwell, E. E. O., Weiler, J. M., & Linhardt, R. J. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0147 · Cited by 168
Sasagawa, T., Pushko, P., Steers, G., et al. (1995) · Virology · doi:10.1016/s0042-6822(95)80027-1 · Cited by 162
Structural polypeptides of rabbit, bovine, and human papillomaviruses
Fãvre, M. (1975) · Journal of Virology · doi:10.1128/jvi.15.5.1239-1247.1975 · Cited by 152
Quantitative Disassembly and Reassembly of Human Papillomavirus Type 11 Viruslike Particles In Vitro
McCarthy, M. P., White, W. I., Palmer‐Hill, F. J., Koenig, S., & Suzich, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.32-41.1998 · Cited by 143
Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure.
Fritz, T. A., Lugemwa, F. N., Sarkar, A. K., & Esko, J. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42349-0 · Cited by 140
Volpers, C., Schirmacher, P., Streeck, R. E., & Sapp, M. J. (1994) · Virology · doi:10.1006/viro.1994.1213 · Cited by 135
Hofmann, K. J., Cook, J. C., Joyce, J. G., et al. (1995) · Virology · doi:10.1006/viro.1995.1283 · Cited by 134
Self-citationGlycosaminoglycan-protein interactions: a question of specificity
Spillmann, D., & Lindahl, U. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90165-1 · Cited by 128
IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
Booth, B. A., Boes, M. K., Dl, A., Dake, B. L., Kiefer, M. C., Maack, C. A., Rj, L., Bar, K., Ee, C., & Weiler, J. M. (1995) · PubMed · Cited by 126
Sandström, J., Karlsson, K., Edlund, H., & Marklund, S. L. (1993) · Biochemical Journal · doi:10.1042/bj2940853 · Cited by 102
Secchiero, P., Sun, D., Vico, A. L. D., Crowley, R. W., Reitz, M. S., Zauli, G., Lusso, P., & Gallo, R. C. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4571-4580.1997 · Cited by 90
Sapp, M. J., Volpers, C., Müller, M., & Streeck, R. E. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2407 · Cited by 86
Hormia, M., Falk-Marzillier, J., Plopper, G. E., Tamura, R. N., Jones, J., & Quaranta, V. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12323451 · Cited by 66
Titration of HPV-11 Infectivity and Antibody Neutralization Can Be Measured In Vitro
Smith, L. H., Foster, C. A., Hitchcock, M. E., Leiserowitz, G. S., Hall, K., Isseroff, R., Christensen, N. D., & Kreider, J. W. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12321173 · Cited by 61
Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase
Karlsson, K., Edlund, A., Sandström, J., & Marklund, S. L. (1993) · Biochemical Journal · doi:10.1042/bj2900623 · Cited by 45
Entry and egress of varicella-zoster virus
Zhu, Z., Gershon, M. D., Gabel, C. A., Sherman, D. L., Ambron, R. T., & Gershon, A. A. (1995) · Neurology · doi:10.1212/wnl.45.12_suppl_8.s15 · Cited by 42
Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae
Carter, J. J., Yaegashi, N., Jenison, S. A., & Galloway, D. A. (1991) · Virology · doi:10.1016/0042-6822(91)90592-y · Cited by 36
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Molecular biology of human papillomavirus infection and cervical cancer
Doorbar, J. (2006) · Clinical Science · doi:10.1042/cs20050369 · Cited by 1,072
Mercer, J., Schelhaas, M., & Helenius, A. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-104626 · Cited by 1,057
Human papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 941
Doorbar, J. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.006 · Cited by 856
Metadata
- Authors
- Joyce, J. G., Tung, J.-S., Przysiecki, C. T., Cook, J. C., Lehman, E. D., Sands, J. A., Jansen, K. U., & Keller, P. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-02
- Volume
- 274
- Issue
- 9
- Pages
- 5810-5822
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2041725513
- Cited by
- 429
- References
- 35
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.